)
CareDx (CDNA) investor relations material
CareDx 47th Annual Raymond James Institutional Investor Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic vision and market overview
Focused on enabling transplant patients to thrive through life-changing solutions and expanding beyond solid organ transplantation with the Transplant Plus roadmap.
Market leadership in solid organ transplantation, supporting over 200 U.S. transplant centers and performing more than 1 million tests.
Total addressable market estimated at $8 billion, with strategic investments in software, medication adherence, and next-generation sequencing kits offered in over 100 countries.
Expansion into adjacent markets, including hematologic cancers, with AlloHeme targeting a $1 billion repeat testing opportunity.
Product innovation and clinical integration
AlloSure suite provides non-invasive, quantitative monitoring for organ rejection, now standard in many centers' surveillance protocols.
Solution selling model drives higher revenue and patient acquisition, with centers adopting multiple products seeing double the testing volume.
Broad adoption of software solutions integrated into clinical workflows, including Epic EMR and LIMS consolidation for streamlined ordering and data exchange.
Strategic collaboration with 10x Genomics and ImmuneScape program leverages multiomics and spatial biology for future diagnostic development.
Financial performance and outlook
Q4 2025 revenue reached $108 million (up 25% YoY), with 53,000 tests performed and a 69% non-GAAP gross margin.
Full-year 2025 revenue was $380 million (up 14% YoY), with $201 million in cash and no debt at year-end.
Adjusted EBITDA for 2025 was $32 million, up 14%, with significant improvements in cash collections and DSO.
2026 guidance projects $420–$444 million in revenue and $30–$45 million in Adjusted EBITDA, factoring in regulatory changes and continued investment in pipeline and commercial readiness.
Next CareDx earnings date
Next CareDx earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)